PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week

T Doenst, A Haverich, P Serruys, RO Bonow… - Journal of the American …, 2019 - jacc.org
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are
considered revascularization procedures, but only CABG can prolong life in stable coronary …

Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn‐Alloys

PK Bowen, ER Shearier, S Zhao… - Advanced …, 2016 - Wiley Online Library
Metallic stents are used to promote revascularization and maintain patency of plaqued or
damaged arteries following balloon angioplasty. To mitigate the long‐term side effects …

[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization

S Windecker, P Kolh, F Alfonso… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Trial of everolimus-eluting stents or bypass surgery for coronary disease

SJ Park, JM Ahn, YH Kim, DW Park… - … England Journal of …, 2015 - Mass Medical Soc
Background Most trials comparing percutaneous coronary intervention (PCI) with coronary-
artery bypass grafting (CABG) have not made use of second-generation drug-eluting stents …

Coronary-artery bypass grafting

JH Alexander, PK Smith - New England Journal of Medicine, 2016 - Mass Medical Soc
Coronary-Artery Bypass Grafting | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Everolimus-eluting stents or bypass surgery for multivessel coronary disease

S Bangalore, Y Guo, Z Samadashvili… - … England Journal of …, 2015 - Mass Medical Soc
Background Results of trials and registry studies have shown lower long-term mortality after
coronary-artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI) …

[HTML][HTML] Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta …

M Kowalewski, W Pawliszak, PG Malvindi… - The Journal of thoracic …, 2016 - Elsevier
Objectives To assess the benefits and risks of off-pump coronary artery bypass (OPCAB)
versus coronary artery bypass grafting (CABG) through a meta-analysis of randomized …

[HTML][HTML] Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis?—a review …

C Spadaccio, U Benedetto - Annals of cardiothoracic surgery, 2018 - ncbi.nlm.nih.gov
The optimal treatment of ischemic coronary artery disease (CAD) is still controversial. A
number of randomized controlled trials (RCT) and several meta-analyses have been …

Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning

J Yang, S Tian, J Zhao, W Zhang - Pharmacological Research, 2020 - Elsevier
Traditional Chinese medicine (TCM) has long been used in the clinical treatment of coronary
heart disease (CHD). TCM is characterized by syndrome-based medication, which is, using …

Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled …

P Gaba, EH Christiansen, PH Nielsen… - JAMA …, 2023 - jamanetwork.com
Importance Patients with left main coronary artery disease presenting with an acute coronary
syndrome (ACS) represent a high-risk and understudied subgroup of patients with …